Cerebral small vessel disease

Cerebral small vessel disease

Cerebral microangiopathy is the second leading cause of dementia after Alzheimer's disease and is a co-factor in the majority of dementias. Its clinical manifestations are multiple and include in addition to cognitive and neuropsychiatric manifestations, also problems of gait, urinary continenc...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Revue médicale suisse 2023-04, Vol.19 (824), p.814
Hauptverfasser: Caranzano, Leonardo, Michel, Patrik
Format: Artikel
Sprache:fre
Schlagworte:
Alzheimer Disease
Cerebral Small Vessel Diseases - diagnosis
Cerebral Small Vessel Diseases - etiology
Cerebral Small Vessel Diseases - therapy
Humans
Magnetic Resonance Imaging
Risk Factors
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 824
container_start_page 814
container_title Revue médicale suisse
container_volume 19
creator Caranzano, Leonardo
Michel, Patrik
description Cerebral microangiopathy is the second leading cause of dementia after Alzheimer's disease and is a co-factor in the majority of dementias. Its clinical manifestations are multiple and include in addition to cognitive and neuropsychiatric manifestations, also problems of gait, urinary continence, and lacunar-ischaemic and haemorrhagic strokes. Patients with similar radiologic images can present very variable clinical pictures, partially resulting from damage to the neurovascular unit, not visible on conventional MRI, and affecting different neural networks. Management and prevention are possible and effective with well-known, readily available and affordable treatments, through aggressive management of cerebrovascular risk factors.
doi_str_mv 10.53738/REVMED.2023.19.824.814
format Article
fullrecord <record><control><sourceid>pubmed</sourceid><recordid>TN_cdi_pubmed_primary_37133942</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>37133942</sourcerecordid><originalsourceid>FETCH-pubmed_primary_371339423</originalsourceid><addsrcrecordid>eNqFjLEKwjAUAN-g2KL9BLU_0Jjk1baZa8Wli4hrSekTKgmUPBT8ex109pZbjgPYKin2WGK1OzfXtjkILTUKZUSlc1GpfAaxKgqZGSxNBAnzXX4oFGqNC4iwVIgm1zGsawrUB-tS9ta59EnM5NJhZLJMK5jfrGNKvl7C5thc6lM2PXpPQzeF0dvw6n4__Bu8ARo8MMM</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Cerebral small vessel disease</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Caranzano, Leonardo ; Michel, Patrik</creator><creatorcontrib>Caranzano, Leonardo ; Michel, Patrik</creatorcontrib><description>Cerebral microangiopathy is the second leading cause of dementia after Alzheimer's disease and is a co-factor in the majority of dementias. Its clinical manifestations are multiple and include in addition to cognitive and neuropsychiatric manifestations, also problems of gait, urinary continence, and lacunar-ischaemic and haemorrhagic strokes. Patients with similar radiologic images can present very variable clinical pictures, partially resulting from damage to the neurovascular unit, not visible on conventional MRI, and affecting different neural networks. Management and prevention are possible and effective with well-known, readily available and affordable treatments, through aggressive management of cerebrovascular risk factors.</description><identifier>ISSN: 1660-9379</identifier><identifier>DOI: 10.53738/REVMED.2023.19.824.814</identifier><identifier>PMID: 37133942</identifier><language>fre</language><publisher>Switzerland</publisher><subject>Alzheimer Disease ; Cerebral Small Vessel Diseases - diagnosis ; Cerebral Small Vessel Diseases - etiology ; Cerebral Small Vessel Diseases - therapy ; Humans ; Magnetic Resonance Imaging ; Risk Factors</subject><ispartof>Revue médicale suisse, 2023-04, Vol.19 (824), p.814</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><orcidid>0000-0003-4954-7579 ; 0000-0001-6395-3683</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27915,27916</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37133942$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Caranzano, Leonardo</creatorcontrib><creatorcontrib>Michel, Patrik</creatorcontrib><title>Cerebral small vessel disease</title><title>Revue médicale suisse</title><addtitle>Rev Med Suisse</addtitle><description>Cerebral microangiopathy is the second leading cause of dementia after Alzheimer's disease and is a co-factor in the majority of dementias. Its clinical manifestations are multiple and include in addition to cognitive and neuropsychiatric manifestations, also problems of gait, urinary continence, and lacunar-ischaemic and haemorrhagic strokes. Patients with similar radiologic images can present very variable clinical pictures, partially resulting from damage to the neurovascular unit, not visible on conventional MRI, and affecting different neural networks. Management and prevention are possible and effective with well-known, readily available and affordable treatments, through aggressive management of cerebrovascular risk factors.</description><subject>Alzheimer Disease</subject><subject>Cerebral Small Vessel Diseases - diagnosis</subject><subject>Cerebral Small Vessel Diseases - etiology</subject><subject>Cerebral Small Vessel Diseases - therapy</subject><subject>Humans</subject><subject>Magnetic Resonance Imaging</subject><subject>Risk Factors</subject><issn>1660-9379</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFjLEKwjAUAN-g2KL9BLU_0Jjk1baZa8Wli4hrSekTKgmUPBT8ex109pZbjgPYKin2WGK1OzfXtjkILTUKZUSlc1GpfAaxKgqZGSxNBAnzXX4oFGqNC4iwVIgm1zGsawrUB-tS9ta59EnM5NJhZLJMK5jfrGNKvl7C5thc6lM2PXpPQzeF0dvw6n4__Bu8ARo8MMM</recordid><startdate>20230426</startdate><enddate>20230426</enddate><creator>Caranzano, Leonardo</creator><creator>Michel, Patrik</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><orcidid>https://orcid.org/0000-0003-4954-7579</orcidid><orcidid>https://orcid.org/0000-0001-6395-3683</orcidid></search><sort><creationdate>20230426</creationdate><title>Cerebral small vessel disease</title><author>Caranzano, Leonardo ; Michel, Patrik</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-pubmed_primary_371339423</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>fre</language><creationdate>2023</creationdate><topic>Alzheimer Disease</topic><topic>Cerebral Small Vessel Diseases - diagnosis</topic><topic>Cerebral Small Vessel Diseases - etiology</topic><topic>Cerebral Small Vessel Diseases - therapy</topic><topic>Humans</topic><topic>Magnetic Resonance Imaging</topic><topic>Risk Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Caranzano, Leonardo</creatorcontrib><creatorcontrib>Michel, Patrik</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>Revue médicale suisse</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Caranzano, Leonardo</au><au>Michel, Patrik</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cerebral small vessel disease</atitle><jtitle>Revue médicale suisse</jtitle><addtitle>Rev Med Suisse</addtitle><date>2023-04-26</date><risdate>2023</risdate><volume>19</volume><issue>824</issue><spage>814</spage><pages>814-</pages><issn>1660-9379</issn><abstract>Cerebral microangiopathy is the second leading cause of dementia after Alzheimer's disease and is a co-factor in the majority of dementias. Its clinical manifestations are multiple and include in addition to cognitive and neuropsychiatric manifestations, also problems of gait, urinary continence, and lacunar-ischaemic and haemorrhagic strokes. Patients with similar radiologic images can present very variable clinical pictures, partially resulting from damage to the neurovascular unit, not visible on conventional MRI, and affecting different neural networks. Management and prevention are possible and effective with well-known, readily available and affordable treatments, through aggressive management of cerebrovascular risk factors.</abstract><cop>Switzerland</cop><pmid>37133942</pmid><doi>10.53738/REVMED.2023.19.824.814</doi><orcidid>https://orcid.org/0000-0003-4954-7579</orcidid><orcidid>https://orcid.org/0000-0001-6395-3683</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1660-9379
ispartof Revue médicale suisse, 2023-04, Vol.19 (824), p.814
issn 1660-9379
language fre
recordid cdi_pubmed_primary_37133942
source MEDLINE; Alma/SFX Local Collection
subjects Alzheimer Disease
Cerebral Small Vessel Diseases - diagnosis
Cerebral Small Vessel Diseases - etiology
Cerebral Small Vessel Diseases - therapy
Humans
Magnetic Resonance Imaging
Risk Factors
title Cerebral small vessel disease
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T01%3A52%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cerebral%20small%20vessel%20disease&rft.jtitle=Revue%20m%C3%A9dicale%20suisse&rft.au=Caranzano,%20Leonardo&rft.date=2023-04-26&rft.volume=19&rft.issue=824&rft.spage=814&rft.pages=814-&rft.issn=1660-9379&rft_id=info:doi/10.53738/REVMED.2023.19.824.814&rft_dat=%3Cpubmed%3E37133942%3C/pubmed%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/37133942&rfr_iscdi=true